Sinocelltech Group Ltd (688520) - Net Assets

Latest as of September 2025: CN¥-730.66 Million CNY ≈ $-106.92 Million USD

Based on the latest financial reports, Sinocelltech Group Ltd (688520) has net assets worth CN¥-730.66 Million CNY (≈ $-106.92 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.76 Billion ≈ $550.42 Million USD) and total liabilities (CN¥4.49 Billion ≈ $657.34 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of Sinocelltech Group Ltd to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥-730.66 Million
% of Total Assets	-19.43%
Annual Growth Rate	6.69%
5-Year Change	-77.07%
10-Year Change	N/A
Growth Volatility	716.13

Sinocelltech Group Ltd - Net Assets Trend (2016–2024)

This chart illustrates how Sinocelltech Group Ltd's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Sinocelltech Group Ltd for the complete picture of this company's asset base.

Annual Net Assets for Sinocelltech Group Ltd (2016–2024)

The table below shows the annual net assets of Sinocelltech Group Ltd from 2016 to 2024. For live valuation and market cap data, see 688520 market cap.

Year	Net Assets	Change
2024-12-31	CN¥134.94 Million ≈ $19.75 Million	+122.27%
2023-12-31	CN¥-605.81 Million ≈ $-88.65 Million	-150.14%
2022-12-31	CN¥-242.19 Million ≈ $-35.44 Million	-4.85%
2021-12-31	CN¥-230.99 Million ≈ $-33.80 Million	-139.26%
2020-12-31	CN¥588.36 Million ≈ $86.10 Million	+1590.51%
2019-12-31	CN¥34.80 Million ≈ $5.09 Million	+245.98%
2018-12-31	CN¥-23.84 Million ≈ $-3.49 Million	-114.21%
2017-12-31	CN¥167.84 Million ≈ $24.56 Million	+108.81%
2016-12-31	CN¥80.38 Million ≈ $11.76 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Sinocelltech Group Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 9587.2% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	CN¥445.34 Million	316.07%
Other Components	CN¥3.51 Billion	2493.71%
Total Equity	CN¥140.90 Million	100.00%

Sinocelltech Group Ltd Competitors by Market Cap

The table below lists competitors of Sinocelltech Group Ltd ranked by their market capitalization.

Company	Market Cap
Scorpio Tankers Inc. F:S0QA	$2.68 Billion
Cargotec Oyj HE:CGCBV	$2.68 Billion
Tarsus Pharmaceuticals Inc NASDAQ:TARS	$2.69 Billion
Anhui Jingcheng Copper Share Co Ltd SHE:002171	$2.69 Billion
Shyam Metalics and Energy Limited NSE:SHYAMMETL	$2.68 Billion
Seadrill Limited NYSE:SDRL	$2.68 Billion
Shenzhen Colibri Technologies Co Ltd SHE:002957	$2.68 Billion
Hybio Pharmaceutical SHE:300199	$2.68 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Sinocelltech Group Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from -599,461,618 to 140,896,888, a change of 740,358,506.
Net income of 111,951,096 contributed positively to equity growth.
Dividend payments of 106,083,912 reduced retained earnings.
Other factors increased equity by 734,491,322.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CN¥111.95 Million	+79.46%
Dividends Paid	CN¥106.08 Million	-75.29%
Other Changes	CN¥734.49 Million	+521.3%
Total Change	CN¥-	%

Book Value vs Market Value Analysis

This analysis compares Sinocelltech Group Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 136.33x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 187.77x to 136.33x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	CN¥0.22	CN¥41.18	x
2017-12-31	CN¥0.46	CN¥41.18	x
2018-12-31	CN¥-0.06	CN¥41.18	x
2019-12-31	CN¥0.08	CN¥41.18	x
2020-12-31	CN¥1.36	CN¥41.18	x
2021-12-31	CN¥-0.52	CN¥41.18	x
2022-12-31	CN¥-0.54	CN¥41.18	x
2023-12-31	CN¥-1.35	CN¥41.18	x
2024-12-31	CN¥0.30	CN¥41.18	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Sinocelltech Group Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 79.46%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 4.46%
• Asset Turnover: 0.77x
• Equity Multiplier: 23.31x
Recent ROE (79.46%) is above the historical average (-258.42%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2016	-14.56%	-12.37%	0.23x	5.06x	CN¥-20.48 Million
2017	-80.53%	-2357.52%	0.01x	2.78x	CN¥-158.82 Million
2018	0.00%	-15387.26%	0.01x	0.00x	CN¥-451.02 Million
2019	-2189.55%	-30122.07%	0.00x	22.27x	CN¥-798.35 Million
2020	-120.59%	-217117.79%	0.00x	2.82x	CN¥-771.59 Million
2021	0.00%	-645.01%	0.10x	0.00x	CN¥-844.20 Million
2022	0.00%	-50.72%	0.37x	0.00x	CN¥-495.33 Million
2023	0.00%	-20.98%	0.69x	0.00x	CN¥-336.07 Million
2024	79.46%	4.46%	0.77x	23.31x	CN¥97.86 Million

Industry Comparison

This section compares Sinocelltech Group Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $787,605,896
Average return on equity (ROE) among peers: -14.82%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Sinocelltech Group Ltd (688520)	CN¥-730.66 Million	-14.56%	N/A	$2.68 Billion
Shenzhen CAU Technology Co Ltd (000004)	$72.91 Million	-180.40%	3.27x	$53.47 Million
Pacific Shuanglin Bio pharmacy Co Ltd (000403)	$458.65 Million	26.71%	1.60x	$1.66 Billion
Nanhua Bio Medicine Co Ltd (000504)	$144.30 Million	-93.32%	1.86x	$443.33 Million
Jiangsu Sihuan Bioengineering Co Ltd (000518)	$1.11 Billion	1.01%	0.26x	$438.41 Million
Chengzhi Shareholding Co Ltd (000990)	$930.16 Million	5.16%	0.80x	$2.24 Billion
Hualan Biological EngineeringInc (002007)	$588.30 Million	13.43%	0.39x	$3.86 Billion
Da An Gene Co Ltd of Sun Yat-Sen University (002030)	$256.72 Million	9.82%	0.22x	$1.19 Billion
Shanghai RAAS Blood Products Co Ltd Class A (002252)	$170.01 Million	48.10%	0.80x	$5.40 Billion
Baolingbao Biology Co Ltd (002286)	$760.53 Million	7.33%	0.46x	$572.48 Million
Tibet Cheezheng Tibetan Medicine Co Ltd (002287)	$3.39 Billion	13.95%	0.74x	$1.90 Billion

About Sinocelltech Group Ltd

SHG:688520 China Biotechnology

Market Cap

$2.68 Billion

CN¥18.34 Billion CNY

Market Cap Rank

#5287 Global

#1047 in China

Share Price

CN¥41.18

Change (1 day)

-0.39%

52-Week Range

CN¥35.89 - CN¥85.63

All Time High

CN¥101.80